1. Home
  2. IKT vs AOUT Comparison

IKT vs AOUT Comparison

Compare IKT & AOUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKT
  • AOUT
  • Stock Information
  • Founded
  • IKT 2008
  • AOUT 2020
  • Country
  • IKT United States
  • AOUT United States
  • Employees
  • IKT N/A
  • AOUT N/A
  • Industry
  • IKT Biotechnology: Pharmaceutical Preparations
  • AOUT Ordnance And Accessories
  • Sector
  • IKT Health Care
  • AOUT Industrials
  • Exchange
  • IKT Nasdaq
  • AOUT Nasdaq
  • Market Cap
  • IKT 111.8M
  • AOUT 93.0M
  • IPO Year
  • IKT 2020
  • AOUT N/A
  • Fundamental
  • Price
  • IKT $1.53
  • AOUT $6.49
  • Analyst Decision
  • IKT Hold
  • AOUT Strong Buy
  • Analyst Count
  • IKT 1
  • AOUT 1
  • Target Price
  • IKT N/A
  • AOUT $19.00
  • AVG Volume (30 Days)
  • IKT 109.4K
  • AOUT 70.6K
  • Earning Date
  • IKT 11-14-2025
  • AOUT 12-04-2025
  • Dividend Yield
  • IKT N/A
  • AOUT N/A
  • EPS Growth
  • IKT N/A
  • AOUT N/A
  • EPS
  • IKT N/A
  • AOUT N/A
  • Revenue
  • IKT N/A
  • AOUT $210,381,000.00
  • Revenue This Year
  • IKT N/A
  • AOUT N/A
  • Revenue Next Year
  • IKT N/A
  • AOUT $7.08
  • P/E Ratio
  • IKT N/A
  • AOUT N/A
  • Revenue Growth
  • IKT N/A
  • AOUT 5.56
  • 52 Week Low
  • IKT $1.33
  • AOUT $6.28
  • 52 Week High
  • IKT $4.20
  • AOUT $17.91
  • Technical
  • Relative Strength Index (RSI)
  • IKT 47.90
  • AOUT 31.53
  • Support Level
  • IKT $1.55
  • AOUT $6.28
  • Resistance Level
  • IKT $1.67
  • AOUT $6.80
  • Average True Range (ATR)
  • IKT 0.13
  • AOUT 0.31
  • MACD
  • IKT 0.01
  • AOUT 0.02
  • Stochastic Oscillator
  • IKT 51.16
  • AOUT 13.86

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About AOUT American Outdoor Brands Inc.

American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.

Share on Social Networks: